عنوان

IASLC thoracic oncology /

شابک

0323527833

شابک

0323527841

شابک

9780323527835

شابک

9780323527842

شابک اشتباه

0323523579

شابک اشتباه

9780323523578

عنوان اصلي

IASLC thoracic oncology /

نام عام مواد

[Book]

نام نخستين پديدآور

executive editor, Harvey I. Pass ; editors, David Ball, Giorgio V. Scagliotti.

وضعيت ويراست

Second edition.

محل نشرو پخش و غیره

Philadelphia, PA :

نام ناشر، پخش کننده و غيره

Elsevier,

تاریخ نشرو بخش و غیره

[2018]

تاریخ نشرو بخش و غیره

©2018

نام خاص و کميت اثر

1 online resource (xiii, 658 pages) :

ساير جزييات

illustrations (some color), color map

متن يادداشت

Revised edition of: The IASLC multidisciplinary approach to thoracic oncology / executive editor, Harvey I. Pass ; editors: David Ball, Giorgio V. Scagliotti. [2014].

متن يادداشت

Includes bibliographical references.

متن يادداشت

Classic epidemiology of lung cancer -- Tobacco control and primary prevention -- Assessing and treating tobacco use in lung cancer care -- Lung cancer in never-smokers : a different disease -- Gender-related differences in lung cancer -- Genetic susceptibility to lung cancer -- Screening for lung cancer -- Preclinical biomarkers for the early detection of lung cancer -- Chemoprevention of lung cancer and management of early lung cancer -- Copy number abnormalities and gene fusions in lung cancer : present and developing technologies -- Mutational events in lung cancer : present and developing technologies -- Epigenetic events in lung cancer : chromatin remodeling and DNA methylation -- Stem cells and lung cancer : in vitro and in vivo studies -- Microenvironment and lung cancer -- Micrornas as biomarkers for lung cancer -- Humoral and cellular immune dysregulation and lung cancer -- Classic anatomic pathology and lung cancer -- Molecular testing in lung cancer -- Management of small histologic and cytologic specimens in the molecular era -- Clinical presentation and prognostic factors in lung cancer -- Conventional imaging of lung cancer -- Positron emission tomography imaging of lung cancer -- Diagnostic workup for suspected lung cancer confined to the chest -- Preoperative and intraoperative invasive staging of the mediastinum -- The eighth edition of the tumor, node, and metastasis classification of lung cancer -- Preoperative functional evaluation of the surgical candidate -- Results of video-assisted techniques for resection of lung cancer -- Robotic surgery : techniques and results for resection of lung cancer -- Extent of surgical resection for stage i and ii lung cancer -- Extended resections for lung cancer : chest wall and pancoast tumors -- Extended resections for lung cancer : bronchovascular sleeve resections -- Multiple nodules : management of synchronous and metachronous lung cancers -- Surgical management of patients considered marginally resectable -- Technical requirements for lung cancer radiotherapy -- Radiobiology of lung cancer -- Patient selection for radiotherapy -- Stage i nonsmall cell lung cancer and oligometastatic disease -- Ablation options for localized nonsmall cell lung cancer -- Radiotherapy for locally advanced nonsmall cell lung cancer including combined modality -- Radiotherapy in the management of small cell lung cancer : thoracic radiotherapy, prophylactic cranial irradiation -- Palliative radiotherapy for lung cancer -- Acute and late toxicities of thoracic radiotherapy : pulmonary, esophagus, and heart -- Neurotoxicity related to radiotherapy and chemotherapy for nonsmall cell and small cell lung cancer -- Frontline systemic therapy options in nonsmall cell lung cancer -- Systemic options for second-line therapy and beyond -- Maintenance chemotherapy for nonsmall cell lung cancer -- Pharmacogenomics in lung cancer : predictive biomarkers for chemotherapy -- New targets for therapy in lung cancer -- Management of toxicities of targeted therapies -- Immunotherapy and lung cancer -- Adjuvant and neoadjuvant chemotherapy for early-stage nonsmall cell lung cancer -- Treatment of extensive-stage small cell lung cancer -- Malignant mesothelioma -- Mediastinal tumors -- Neuroendocrine tumors of the lung other than small cell lung cancer -- Thymic tumors -- Lung cancer emergencies -- The role of palliative care in lung cancer -- Clinical trial methodology in lung cancer : study design and end-point considerations -- How to promote and organize clinical research in lung cancer -- The role of advocacy groups in lung cancer -- The role of health services research in improving the outcomes for patients with lung cancer.

بدون عنوان

0

متن يادداشت

Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today's best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. Written in a straightforward, practical style for the busy clinician, this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies.

عنوان

IASLC thoracic oncology.

شماره استاندارد بين المللي کتاب و موسيقي

9780323523578

عنوان قراردادي

IASLC multidisciplinary approach to thoracic oncology.

عنوان اصلي به زبان ديگر

International Association for the Study of Lung Cancer thoracic oncology

عنوان اصلي به زبان ديگر

Thoracic oncology

موضوع مستند نشده

Lungs-- Cancer.

موضوع مستند نشده

Thoracic Neoplasms, Electronic Books.

موضوع مستند نشده

Thoracic Neoplasms.

موضوع مستند نشده

Lungs-- Cancer.

شماره

ويراست

شماره رده

شماره رده

مستند نام اشخاص تاييد نشده

Ball, David, (David L.)

مستند نام اشخاص تاييد نشده

Pass, Harvey I.

مستند نام اشخاص تاييد نشده

Scagliotti, Giorgio V.

مستند نام تنالگان تاييد نشده

International Association for the Study of Lung Cancer,issuing body.

تاريخ عمليات

20200822095553.0

قواعد فهرست نويسي ( بخش توصيفي )

pn

نام الکترونيکي

نوع ماده

[Book]

تكميل شده

Y